非侵襲的冠動脈イメージング市場の成長と動向分析レポート

Non-invasive Coronary Imaging Market Growth & Trends

The global non-invasive coronary imaging market size is expected to reach USD 596.8 million by 2030, registering a CAGR of 6.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. Need to diagnose critical cardiac conditions in a short time span, increased deaths by coronary artery diseases, the growing geriatric population, and the growing need to avoid complications of invasive coronary imaging. Coronary artery disease is the leading cause of death in all regions across the globe. According to the Centers for Disease Control and Prevention, to date, 20.1 million adults have CAD. In 2020, 2 in every 10 geriatric patients above the age of 65, died due to CAD.

世界の非侵襲性冠状動脈イメージング市場規模は2030年までに5億9,680万米ドルに達すると予想され、2025年から2030年までに6.6%のCAGRを記録すると予想されています。

Non-invasive imaging has recently been utilized to assess the existence, severity, and prognosis of coronary artery disease as a result of advancements in imaging technology. The anatomical importance of coronary artery stenosis can be determined by stress myocardial perfusion imaging, such as SPECT/PET and stress MRI, whereas coronary CT angiography and MRI of the coronary arteries give anatomical assessments of coronary stenosis. Studies published in the National Center for Biotechnology Information (NCBI), stated that CT angiography showed promising results in the detection of CAD.

Its sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 94%, 83%, 48%, and 99%, respectively, to detect 70% stenosis. Thus, CT angiography shows promising results as a valuable tool for the diagnosis of significant coronary artery disease. Another research study published in NCBI shows promising results of noninvasive cardiac MR over echocardiography. The study compared dobutamine stress CMR (DSMR) with dobutamine stress echocardiography (DSE) in the detection of CAD (≥50% stenosis) using ICA as the gold standard. It resulted that, DSMR has higher diagnostic accuracy than that DSE in patients with suspected CAD.

The outbreak of the COVID-19 pandemic led to a decline in research activities, the closure of universities and academic institutions, and a decline in clinical trial activities. The fear of virus spread also declined any diagnostic or surgical activities at end-use settings. The economic crunch at hospitals, diagnostic centers, or clinics, led to the reduced adoption of software and systems for non-invasive diagnosis. Thus, the pandemic led to a decline in the market in 2020.

Non-invasive Coronary Imaging Market Report Scope

Non-invasive Coronary Imaging Market Report Highlights

• The Echocardiography segment dominated the market by capturing a share of 33.1% in 2024. This dominance can be attributed to factors such as its cost-effectiveness, widespread availability, and non-invasive nature, making it a preferred choice for routine cardiovascular assessments.

• The hospital segment dominated the market by capturing a share of 42.6% in 2024. This is owing to the growing number of patient visits to hospitals, driven by the increasing prevalence of cardiovascular diseases.

• North America non-invasive coronary imaging market held the largest share of 38% in 2024. This dominance is primarily attributed to the presence of major market players in the region and their strategic efforts to strengthen their presence.

• Asia Pacific non-invasive coronary imaging market is expected to witness the fastest growth of CAGR 6.9% over the forecast period. This rapid growth is largely attributed to the expanding healthcare sectors in key countries such as China, India and Japan.

Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.2. Segment Definitions

1.2.1. Modality

1.2.2. End Use

1.2.3. Regional scope

1.2.4. Estimates and forecasts timeline

1.3. Research Methodology

1.4. Information Procurement

1.4.1. Purchased database

1.4.2. GVR’s internal database

1.4.3. Secondary sources

1.4.4. Primary research

1.4.5. Details of primary research

1.4.5.1. Data for primary interviews in North America

1.4.5.2. Data for primary interviews in Europe

1.4.5.3. Data for primary interviews in Asia Pacific

1.4.5.4. Data for primary interviews in Latin America

1.4.5.5. Data for Primary interviews in MEA

1.5. Information or Data Analysis

1.5.1. Data analysis models

1.6. Market Formulation & Validation

1.7. Model Details

1.7.1. Commodity flow analysis (Model 1)

1.7.2. Approach 1: Commodity flow approach

1.7.3. Volume price analysis (Model 2)

1.7.4. Approach 2: Volume price analysis

1.8. List of Secondary Sources

1.9. List of Primary Sources

1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.2.1. Modality outlook

2.2.2. End Use outlook

2.2.3. Regional outlook

2.3. Competitive Insights

Chapter 3. Non-invasive Coronary Imaging Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market driver analysis

3.2.1.1. Rising prevalence of cardiac diseases

3.2.1.2. Need for advancements diagnostic tools

3.2.1.3. Increasing geriatric population

3.2.2. Market restraint analysis

3.2.2.1. Lack of reliable and guaranteed clinical trial data

3.2.2.2. Complex regulatory environment

3.3. Non-invasive Coronary Imaging Market Analysis Tools

3.3.1. Industry Analysis – Porter’s

3.3.1.1. Supplier power

3.3.1.2. Buyer power

3.3.1.3. Substitution threat

3.3.1.4. Threat of new entrant

3.3.1.5. Competitive rivalry

3.3.2. PESTEL Analysis

3.3.2.1. Political landscape

3.3.2.2. Technological landscape

3.3.2.3. Economic landscape

Chapter 4. Non-invasive Coronary Imaging Market: Modality Estimates & Trend Analysis

4.1. Segment Dashboard

4.2. Global Non-invasive Coronary Imaging Modality Market Movement Analysis

4.3. Global Non-invasive Coronary Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)

4.4. Radionuclide Cardiac Imaging

4.4.1. Radionuclide cardiac imaging market estimates and forecasts 2018 to 2030 (USD Million)

4.5. Echocardiography

4.5.1. Echocardiography market estimates and forecasts 2018 to 2030 (USD Million)

4.6. Cardiac Computed Tomography

4.6.1. Cardiac computed tomography market estimates and forecasts 2018 to 2030 (USD Million)

4.7. Cardiac Magnetic Resonance Imaging

4.7.1. Cardiac magnetic resonance imaging market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Non-invasive Coronary Imaging Market: End Use Estimates & Trend Analysis

5.1. Segment Dashboard

5.2. Global Non-invasive Coronary Imaging End Use Market Movement Analysis

5.3. Global Non-invasive Coronary Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)

5.4. Hospitals

5.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)

5.5. Diagnostic Imaging Centers

5.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)

5.6. Research Institutes

5.6.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Non-invasive Coronary Imaging Market: Regional Estimates & Trend Analysis By Modality, End Use

6.1. Regional Market Share Analysis, 2024 & 2030

6.2. Regional Market Dashboard

6.3. Global Regional Market Snapshot

6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:

6.5. North America

6.5.1. U.S.

6.5.1.1. Key country dynamics

6.5.1.2. Competitive scenario

6.5.1.3. Regulatory framework

6.5.1.4. Reimbursement structure

6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)

6.5.2. Canada

6.5.2.1. Key country dynamics

6.5.2.2. Competitive scenario

6.5.2.3. Regulatory framework

6.5.2.4. Reimbursement structure

6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)

6.5.3. Mexico

6.5.3.1. Key country dynamics

6.5.3.2. Competitive scenario

6.5.3.3. Regulatory framework

6.5.3.4. Reimbursement structure

6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)

6.6. Europe

6.6.1. UK

6.6.1.1. Key country dynamics

6.6.1.2. Competitive scenario

6.6.1.3. Regulatory framework

6.6.1.4. Reimbursement structure

6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)

6.6.2. Germany

6.6.2.1. Key country dynamics

6.6.2.2. Competitive scenario

6.6.2.3. Regulatory framework

6.6.2.4. Reimbursement structure

6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)

6.6.3. France

6.6.3.1. Key country dynamics

6.6.3.2. Competitive scenario

6.6.3.3. Regulatory framework

6.6.3.4. Reimbursement structure

6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)

6.6.4. Italy

6.6.4.1. Key country dynamics

6.6.4.2. Competitive scenario

6.6.4.3. Regulatory framework

6.6.4.4. Reimbursement structure

6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)

6.6.5. Spain

6.6.5.1. Key country dynamics

6.6.5.2. Competitive scenario

6.6.5.3. Regulatory framework

6.6.5.4. Reimbursement structure

6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)

6.6.6. Norway

6.6.6.1. Key country dynamics

6.6.6.2. Competitive scenario

6.6.6.3. Regulatory framework

6.6.6.4. Reimbursement structure

6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)

6.6.7. Sweden

6.6.7.1. Key country dynamics

6.6.7.2. Competitive scenario

6.6.7.3. Regulatory framework

6.6.7.4. Reimbursement structure

6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)

6.6.8. Denmark

6.6.8.1. Key country dynamics

6.6.8.2. Competitive scenario

6.6.8.3. Regulatory framework

6.6.8.4. Reimbursement structure

6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)

6.7. Asia Pacific

6.7.1. Japan

6.7.1.1. Key country dynamics

6.7.1.2. Competitive scenario

6.7.1.3. Regulatory framework

6.7.1.4. Reimbursement structure

6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)

6.7.2. China

6.7.2.1. Key country dynamics

6.7.2.2. Competitive scenario

6.7.2.3. Regulatory framework

6.7.2.4. Reimbursement structure

6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)

6.7.3. India

6.7.3.1. Key country dynamics

6.7.3.2. Competitive scenario

6.7.3.3. Regulatory framework

6.7.3.4. Reimbursement structure

6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)

6.7.4. Australia

6.7.4.1. Key country dynamics

6.7.4.2. Competitive scenario

6.7.4.3. Regulatory framework

6.7.4.4. Reimbursement structure

6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)

6.7.5. South Korea

6.7.5.1. Key country dynamics

6.7.5.2. Competitive scenario

6.7.5.3. Regulatory framework

6.7.5.4. Reimbursement structure

6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)

6.7.6. Thailand

6.7.6.1. Key country dynamics

6.7.6.2. Competitive scenario

6.7.6.3. Regulatory framework

6.7.6.4. Reimbursement structure

6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)

6.8. Latin America

6.8.1. Brazil

6.8.1.1. Key country dynamics

6.8.1.2. Competitive scenario

6.8.1.3. Regulatory framework

6.8.1.4. Reimbursement structure

6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)

6.8.2. Argentina

6.8.2.1. Key country dynamics

6.8.2.2. Competitive scenario

6.8.2.3. Regulatory framework

6.8.2.4. Reimbursement structure

6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)

6.9. MEA

6.9.1. South Africa

6.9.1.1. Key country dynamics

6.9.1.2. Competitive scenario

6.9.1.3. Regulatory framework

6.9.1.4. Reimbursement structure

6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)

6.9.2. Saudi Arabia

6.9.2.1. Key country dynamics

6.9.2.2. Competitive scenario

6.9.2.3. Regulatory framework

6.9.2.4. Reimbursement structure

6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)

6.9.3. UAE

6.9.3.1. Key country dynamics

6.9.3.2. Competitive scenario

6.9.3.3. Regulatory framework

6.9.3.4. Reimbursement structure

6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)

6.9.4. Kuwait

6.9.4.1. Key country dynamics

6.9.4.2. Competitive scenario

6.9.4.3. Regulatory framework

6.9.4.4. Reimbursement structure

6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants

7.2. Company/Competition Categorization

7.3. Key company market share analysis, 2024

7.4. Company Position Analysis

7.5. Company Categorization (Emerging Players, Innovators and Leaders

7.6. Company Profiles

7.6.1. GE HealthCare

7.6.1.1. Company overview

7.6.1.2. Financial performance

7.6.1.3. Product benchmarking

7.6.1.4. Strategic initiatives

7.6.2. Koninklijke Philips N.V.

7.6.2.1. Company overview

7.6.2.2. Financial performance

7.6.2.3. Product benchmarking

7.6.2.4. Strategic initiatives

7.6.3. Siemens Healthineers AG

7.6.3.1. Company overview

7.6.3.2. Financial performance

7.6.3.3. Product benchmarking

7.6.3.4. Strategic initiatives

7.6.4. Canon Medical Systems Corporation

7.6.4.1. Company overview

7.6.4.2. Financial performance

7.6.4.3. Product benchmarking

7.6.4.4. Strategic initiatives

7.6.5. Neusoft Medical Systems

7.6.5.1. Company overview

7.6.5.2. Financial performance

7.6.5.3. Product benchmarking

7.6.5.4. Strategic initiatives

7.6.6. United Imaging Healthcare

7.6.6.1. Company overview

7.6.6.2. Financial performance

7.6.6.3. Product benchmarking

7.6.6.4. Strategic initiatives

7.6.7. Esaote SpA

7.6.7.1. Company overview

7.6.7.2. Financial performance

7.6.7.3. Product benchmarking

7.6.7.4. Strategic initiatives

7.6.8. Fujifilm Holdings Corporation

7.6.8.1. Company overview

7.6.8.2. Financial performance

7.6.8.3. Product benchmarking

7.6.8.4. Strategic initiatives

7.6.9. Shimadzu Corporation

7.6.9.1. Company overview

7.6.9.2. Financial performance

7.6.9.3. Product benchmarking

7.6.9.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources

Table 2 List of abbreviation

Table 3 North America non-invasive coronary imaging market, By country, 2018 – 2030 (USD Million)

Table 4 North America non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 5 North America non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 6 U.S. non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 7 U.S. non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 8 Canada non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 9 Canada non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 10 Mexico non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 11 Mexico non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 12 Europe non-invasive coronary imaging market, By country, 2018 – 2030 (USD Million)

Table 13 Europe non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 14 Europe non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 15 UK non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 16 UK non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 17 Germany non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 18 Germany non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 19 France non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 20 France non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 21 Italy non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 22 Italy non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 23 Denmark non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 24 Denmark non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 25 Sweden non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 26 Sweden non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 27 Norway non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 28 Norway non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 29 Asia Pacific non-invasive coronary imaging market, By country, 2018 – 2030 (USD Million)

Table 30 Asia Pacific non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 31 Asia Pacific non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 32 Japan non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 33 Japan non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 34 China non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 35 China non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 36 India non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 37 India non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 38 Australia non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 39 Australia non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 40 South Korea non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 41 South Korea non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 42 Thailand non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 43 Thailand non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 44 Latin America non-invasive coronary imaging market, By Country, 2018 – 2030 (USD Million)

Table 45 Latin America non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 46 Latin America non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 47 Brazil non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 48 Brazil non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 49 Argentina non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 50 Argentina non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 51 Middle East & Africa non-invasive coronary imaging market, By country, 2018 – 2030 (USD Million)

Table 52 Middle East & Africa non-invasive coronary imaging market, By modality, 2018 – 2030 (USD

Table 53 Middle East & Africa non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 54 South Africa non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 55 South Africa non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 56 Saudi Arabia non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 57 Saudi Arabia non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 58 UAE non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 59 UAE non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

Table 60 Kuwait non-invasive coronary imaging market, By modality, 2018 – 2030 (USD Million)

Table 61 Kuwait non-invasive coronary imaging market, By end-use, 2018 – 2030 (USD Million)

List of Figures

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Primary interviews in North America

Fig. 5 Primary interviews in Europe

Fig. 6 Primary interviews in APAC

Fig. 7 Primary interviews in Latin America

Fig. 8 Primary interviews in MEA

Fig. 9 Market research approaches

Fig. 10 Value-chain-based sizing & forecasting

Fig. 11 QFD modeling for market share assessment

Fig. 12 Market formulation & validation

Fig. 13 Non-Invasive Coronary Imaging market: market outlook

Fig. 14 Parent market outlook

Fig. 15 Related/ancillary market outlook

Fig. 16 Penetration and growth prospect mapping

Fig. 17 Industry value chain analysis

Fig. 18 Non-Invasive Coronary Imaging market driver impact

Fig. 19 Non-Invasive Coronary Imaging market restraint impact

Fig. 20 Non-Invasive Coronary Imaging market: Modality movement analysis

Fig. 21 Non-Invasive Coronary Imaging market: Modality outlook and key takeaways

Fig. 22 Radionuclide cardiac imaging market estimates and forecast, 2018 – 2030

Fig. 23 Echocardiography market estimates and forecast, 2018 – 2030

Fig. 24 Cardiac computed tomography market estimates and forecast, 2018 – 2030

Fig. 25 Cardiac magnetic resonance imaging market estimates and forecast, 2018 – 2030

Fig. 26 Non-Invasive Coronary Imaging market: End-use movement analysis

Fig. 27 Non-Invasive Coronary Imaging market: End-use outlook and key takeaways

Fig. 28 Hospitals market estimates and forecast, 2018 – 2030

Fig. 29 Diagnostic imaging centers market estimates and forecast, 2018 – 2030

Fig. 30 Research institutes market estimates and forecast, 2018 – 2030

Fig. 31 Global non-invasive coronary imaging market: Regional movement analysis

Fig. 32 Global non-invasive coronary imaging market: Regional outlook and key takeaways

Fig. 33 North America

Fig. 34 North America market estimates and forecasts, 2018 – 2030

Fig. 35 U.S.

Fig. 36 U.S. market estimates and forecasts, 2018 – 2030

Fig. 37 Canada

Fig. 38 Canada market estimates and forecasts, 2018 – 2030

Fig. 39 Mexico

Fig. 40 Mexico market estimates and forecasts, 2018 – 2030

Fig. 41 Europe

Fig. 42 Europe market estimates and forecasts, 2018 – 2030

Fig. 43 UK

Fig. 44 UK market estimates and forecasts, 2018 – 2030

Fig. 45 Germany

Fig. 46 Germany market estimates and forecasts, 2018 – 2030

Fig. 47 France

Fig. 48 France market estimates and forecasts, 2018 – 2030

Fig. 49 Italy

Fig. 50 Italy market estimates and forecasts, 2018 – 2030

Fig. 51 Spain

Fig. 52 Spain market estimates and forecasts, 2018 – 2030

Fig. 53 Denmark

Fig. 54 Denmark market estimates and forecasts, 2018 – 2030

Fig. 55 Sweden

Fig. 56 Sweden market estimates and forecasts, 2018 – 2030

Fig. 57 Norway

Fig. 58 Norway market estimates and forecasts, 2018 – 2030

Fig. 59 Asia Pacific

Fig. 60 Asia Pacific market estimates and forecasts, 2018 – 2030

Fig. 61 China

Fig. 62 China market estimates and forecasts, 2018 – 2030

Fig. 63 Japan

Fig. 64 Japan market estimates and forecasts, 2018 – 2030

Fig. 65 India

Fig. 66 India market estimates and forecasts, 2018 – 2030

Fig. 67 Thailand

Fig. 68 Thailand market estimates and forecasts, 2018 – 2030

Fig. 69 South Korea

Fig. 70 South Korea market estimates and forecasts, 2018 – 2030

Fig. 71 Australia

Fig. 72 Australia market estimates and forecasts, 2018 – 2030

Fig. 73 Latin America

Fig. 74 Latin America market estimates and forecasts, 2018 – 2030

Fig. 75 Brazil

Fig. 76 Brazil market estimates and forecasts, 2018 – 2030

Fig. 77 Argentina

Fig. 78 Argentina market estimates and forecasts, 2018 – 2030

Fig. 79 Middle East and Africa

Fig. 80 Middle East and Africa market estimates and forecasts, 2018 – 2030

Fig. 81 South Africa

Fig. 82 South Africa market estimates and forecasts, 2018 – 2030

Fig. 83 Saudi Arabia

Fig. 84 Saudi Arabia market estimates and forecasts, 2018 – 2030

Fig. 85 UAE

Fig. 86 UAE market estimates and forecasts, 2018 – 2030

Fig. 87 Kuwait

Fig. 88 Kuwait market estimates and forecasts, 2018 – 2030

Fig. 89 Market share of key market players- Non-Invasive Coronary Imaging market

Grand View Researchについて

Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ 1

ライセンスタイプ 2

ライセンスタイプ 3

ライセンスタイプ 4

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス（インディビジュアルライセンス）
    • 1名のみレポートファイル（印刷不可）をご利用いただけます。
  • チームライセンス
    • 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
  • コーポレートライセンス
    • 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
    • 「関連会社」の範囲についてはお気軽にお問い合わせください。
• 納品形態
  • オンラインダウンロード
• 納期
  • ご注文後1～7営業日　※レポートにより異なります。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• ARクラウド市場規模、成長と動向分析レポート 2025-2033年
• ノーコードAIプラットフォーム市場規模、成長と動向分析レポート 2025-2033年
• 量子コンピューティングにおけるAI最適化市場規模、成長と動向分析レポート 2025-2033年
• ワイヤレス状態監視システム市場規模、成長と動向分析レポート 2025-2033年
• ゲームストリーミング市場規模、成長と動向分析レポート 2025-2033年

出版レポート一覧